U.S.-based art collective Kanbas made the largest non-fungible token (NFT) purchase in three years last week, scooping up a 1 ...

Nearly 10 million free Aibo NFTs have been minted on Soneium, Sony's Ethereum layer-2 network, granting them tokens that ...

Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported 2024 financial and operational results posting revenues of $167 million, a 27% rise over prior year levels. Drivers for the result were a 30% ...

The SEC’s decision to close the case reinforces the view industry proponents held—that NFTs do not fall under existing ...

RBC Capital analyst Douglas Miehm reiterated a Buy rating on Ligand Pharma (LGND – Research Report) yesterday and set a price target of $155.00. The company’s shares closed last Friday at $122.23.

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Ligand Pharma (LGND – Research Report). The company’s shares closed last Friday at $120.67. See what stocks ...

Octavio Espinoza, the Chief Financial Officer of $LGND, sold 5,000 shares of the company on 03-04-2025 for an estimated $575,148. We received data on the trade from a ...

Amalgamated Bank grew its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Several institutional investors and hedge funds have recently added to or ...

Last week, the US-based collecter Kanbas purchased Sam Spratt’s unique NFT artwork for $3 million. This purchase marks the biggest non-fungible token sale in three years and indicates a potential ...

JUPITER, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo ...